SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-23-004723
Filing Date
2023-03-27
Accepted
2023-03-27 16:41:44
Documents
87
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ampe-20221231x10k.htm   iXBRL 10-K 1749852
2 EX-23.1 ampe-20221231xex23d1.htm EX-23.1 2620
3 EX-31.1 ampe-20221231xex31d1.htm EX-31.1 8667
4 EX-31.2 ampe-20221231xex31d2.htm EX-31.2 8244
5 EX-32.1 ampe-20221231xex32d1.htm EX-32.1 8106
6 GRAPHIC ampe-20221231x10k004.jpg GRAPHIC 3040
  Complete submission text file 0001558370-23-004723.txt   8512285

Data Files

Seq Description Document Type Size
7 EX-101.SCH ampe-20221231.xsd EX-101.SCH 67209
8 EX-101.CAL ampe-20221231_cal.xml EX-101.CAL 54281
9 EX-101.DEF ampe-20221231_def.xml EX-101.DEF 239571
10 EX-101.LAB ampe-20221231_lab.xml EX-101.LAB 453510
11 EX-101.PRE ampe-20221231_pre.xml EX-101.PRE 419332
81 EXTRACTED XBRL INSTANCE DOCUMENT ampe-20221231x10k_htm.xml XML 1706011
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35182 | Film No.: 23765021
SIC: 2834 Pharmaceutical Preparations